+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

From
Chronic Spontaneous Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Graves' Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
Autoimmune Gastrointestinal Dysmotility Market Report 2026 - Product Thumbnail Image

Autoimmune Gastrointestinal Dysmotility Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Febrile Neutropenia Market Report 2026 - Product Thumbnail Image

Febrile Neutropenia Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Digital Therapeutics for Fibromyalgia Market Report 2026 - Product Thumbnail Image

Digital Therapeutics for Fibromyalgia Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Digital Therapeutics Endometriosis Market Report 2026 - Product Thumbnail Image

Digital Therapeutics Endometriosis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more